These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Multimorbidity and use of hypnotic and anxiolytic drugs: cross-sectional and follow-up study in primary healthcare in Iceland. Linnet K; Gudmundsson LS; Birgisdottir FG; Sigurdsson EL; Johannsson M; Tomasdottir MO; Sigurdsson JA BMC Fam Pract; 2016 Jun; 17():69. PubMed ID: 27267943 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of use of medically prescribed hypnotics among adult Japanese women in urban residential areas. Kageyama T; Kabuto M; Nitta H; Kurokawa Y; Taira K; Suzuki S; Takemoto TI Psychiatry Clin Neurosci; 1998 Feb; 52(1):69-74. PubMed ID: 9682936 [TBL] [Abstract][Full Text] [Related]
15. Risk of psychiatric disorders in patients with chronic insomnia and sedative-hypnotic prescription: a nationwide population-based follow-up study. Chung KH; Li CY; Kuo SY; Sithole T; Liu WW; Chung MH J Clin Sleep Med; 2015 Apr; 11(5):543-51. PubMed ID: 25766696 [TBL] [Abstract][Full Text] [Related]
16. Chronic use of hypnotics in a family practice--patients' reluctance to stop treatment. Matalon A; Yinnon AM; Hurwitz A Fam Pract; 1990 Dec; 7(4):258-60. PubMed ID: 2289635 [TBL] [Abstract][Full Text] [Related]
17. Factors associated with long-term use of hypnotics among patients with chronic insomnia. Takaesu Y; Komada Y; Asaoka S; Kagimura T; Inoue Y PLoS One; 2014; 9(11):e113753. PubMed ID: 25409018 [TBL] [Abstract][Full Text] [Related]
18. Report of two cases where sleep related eating behavior occurred with the extended-release formulation but not the immediate-release formulation of a sedative-hypnotic agent. Chiang A; Krystal A J Clin Sleep Med; 2008 Apr; 4(2):155-6. PubMed ID: 18468314 [TBL] [Abstract][Full Text] [Related]